← Back to Treatments
🏅 FDA Orphan Designation

ATryn

recombinant human antithrombin

Manufacturer: GTC Biotherapeutics, Inc.

Indicated for:
Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndromeOrphanAceruloplasminemiaOrphan

FDA-Approved Indications (2)

Prevention of peri-operative and peri-partum thromboembolic events, in hereditary antithrombin deficient patients.

AceruloplasminemiaOrphan Designation

Prevention of peri-operative and peri-partum thromboembolic events, in hereditary antithrombin deficient patients

Population: all ages

Indications & Usage

Prevention of peri-operative and peri-partum thromboembolic events, in hereditary antithrombin deficient patients.

💙 Support Programs

View all →
ATryn
GTC Biotherapeutics, Inc.
ATryn
GTC Biotherapeutics, Inc.

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.